70.85
price down icon2.48%   -1.80
after-market Handel nachbörslich: 66.92 -3.93 -5.55%
loading

Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.52%
127.78
111.58 99.41 90.38 77.88
Operating Expenses
4.74%
132.77
126.77 123.64 103.06 102.11
Benefits Costs and Expenses
6.40%
133.24
125.23 123.78 104.27 101.88
Costs And Expenses
6.40%
133.24
125.23 123.78 104.27 101.88
Operating Income/Loss
67.14%
-4.989
-15.18 -24.22 -12.68 -24.23
Income/Loss From Continuing Operations Before Tax
60.00%
-5.459
-13.65 -24.37 -13.89 -24.00
Income Tax Expense/Benefit
60.93%
0.402
1.029 -0.576 0.347 0.635
Income/Loss From Continuing Operations After Tax
60.07%
-5.861
-14.68 -23.79 -14.23 -24.64
Net Income/Loss
60.07%
-5.861
-14.68 -23.79 -14.23 -24.64
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.71%
49.73
48.89 0.2058 47.78 47.24
Diluted Average Shares
1.71%
49.73
48.89 0.2058 47.78 47.24
Basic Earnings Per Share
60.00%
-0.12
-0.30 -0.49 -0.30 -0.52
Diluted Earnings Per Share
60.00%
-0.12
-0.30 -0.49 -0.30 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):